Crossmark

Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers

Crossref DOI link: https://doi.org/10.1186/s40478-018-0579-0

Published Online: 2018-08-03

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Frick, Petra

Sellier, Chantal

Mackenzie, Ian R. A.

Cheng, Chieh-Yu

Tahraoui-Bories, Julie

Martinat, Cecile

Pasterkamp, R. Jeroen

Prudlo, Johannes

Edbauer, Dieter

Oulad-Abdelghani, Mustapha

Feederle, Regina

Charlet-Berguerand, Nicolas

Neumann, Manuela http://orcid.org/0000-0002-6232-4057
Funding

Funding for this research was provided by:

Helmholtz-Gemeinschaft (W2/W3-036, VHVI-510)

NOMIS Stiftung

Fondation Thierry Latran (57486)

AFM-Téléthon (18605)

European Research Council (ERC-2012-StG 310659, ERC-2013-CoG 6117198)

Canadian Institutes of Health Research (74580)

Canadian Consortium on Neurodegeneration in Aging (137794)

Dutch ALS Foundation (TOTALS)

Munich Cluster of Systems Neurology

Munich Cluster of Systems Neurology
License Information

Text and Data Mining valid from 2018-08-03
More Information

Article History

Received: 27 July 2018

Accepted: 28 July 2018

First Online: 3 August 2018

Competing interests

: The authors declare that they have no competing interests

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.